Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today
Aura AI Summary
Key Stats
- $130.87BMarket Cap
- 887,319Volume
- HealthSector
- $557.9652W High
- $376.6252W Low
- 117 DaysTypical Hold Time
- $125.00BEnterprise Value
- -Div Yield
- 93% Sell | 7% BuyTrading Activity
Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $376.62 and a high of $557.96, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
On Holding enters football market with Kylian Mbappé partnership, shares volatile despite 'Underperform' rating.
On Holding, a Swiss athletic shoe company, is expanding into the global football market by partnering with soccer star Kylian Mbappé, who leaves Nike after nearly 20 years. This marks On Holding's first venture into football cleats and apparel, lever...
Peter Thiel's fund re-enters market with $419M, heavily investing 72% in energy and power sectors.
Peter Thiel's investment fund, which held no stocks for two consecutive quarters, has made a significant comeback with $419 million in new investments. Notably, 72% of this capital has been allocated to the energy and power sectors, signaling a strat...
Gold holds steady despite Fed rate hike, supported by fiscal concerns and geopolitical risks.
Gold prices remain resilient, holding critical support after the Federal Reserve raised interest rates by 25 basis points and signaled further tightening. Analysts attribute gold's strength to broader structural factors such as deteriorating governme...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.